Dr. Reddy’s Elyxyb (celecoxib oral solution) Receives the US FDA’s Approval for Acute Treatment of Migraine with or Without Aura in Adults

 Dr. Reddy’s Elyxyb (celecoxib oral solution) Receives the US FDA’s Approval for Acute Treatment of Migraine with or Without Aura in Adults

Dr. Reddy’s Laboratories Launches Versavo (biosimilar, bevacizumab) for Multiple Cancers in India

Shots:

  • ELYXYB (previously as DFN-15) is an oral solution formulated using a self-micro emulsifying drug delivery system helps in improving solubility and bioavailability of the drug leading for absorption
  • The candidate demonstrated a rapid onset of actions important for suffering from acute migraine and resulted in efficacy with few AEs
  • NSAIDs including ELYXYB can lead to increase the risk of bleeding events also co-morbid conditions such as coagulation disorders

Click here to read full press release/ article | Ref: Business Wire | Image: Twitter

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post